Published in Open Med on October 27, 2009
Small studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological study. Crit Care (2013) 1.43
Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials. Crit Care (2010) 0.98
Concerning Chapter 5 - Human Albumin; in Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives, 4th ed. Transfus Med Hemother 2009;36(6):399-407. Transfus Med Hemother (2010) 0.92
Systematic analysis of hydroxyethyl starch (HES) reviews: proliferation of low-quality reviews overwhelms the results of well-performed meta-analyses. Intensive Care Med (2012) 0.89
Effects of different resuscitation fluids on pulmonary expression of aquaporin1 and aquaporin5 in a rat model of uncontrolled hemorrhagic shock and infection. PLoS One (2013) 0.85
Relative survival benefit and morbidity with fluids in severe sepsis - a network meta-analysis of alternative therapies. Curr Drug Saf (2013) 0.84
Crystalloids vs. colloids: KO at the twelfth round? Crit Care (2013) 0.81
[State of the art in fluid and volume therapy : A user-friendly staged concept]. Anaesthesist (2017) 0.81
Are renal adverse effects of hydroxyethyl starches merely a consequence of their incorrect use? Wien Klin Wochenschr (2011) 0.78
Choice of Fluids in Severe Septic Patients - A Cost-effectiveness Analysis Informed by Recent Clinical Trials. Rev Recent Clin Trials (2014) 0.77
Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials (1996) 64.38
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA (1995) 45.41
Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med (2008) 19.93
Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA (2005) 19.57
Identifying relevant studies for systematic reviews. BMJ (1994) 12.21
RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care (2006) 9.29
Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA (2000) 5.94
Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med (2007) 5.80
Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet (2001) 4.17
Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care (2005) 3.96
The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med (2008) 3.64
Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet (1996) 3.48
Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med (1999) 2.67
A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med (1995) 2.49
Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev (2007) 2.45
Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth (2007) 2.41
Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med (1983) 2.36
Renal impact of fluid management with colloids: a comparative review. Eur J Anaesthesiol (2006) 2.22
Retracted The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg (1996) 2.04
Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int (2003) 1.80
The effects of hydroxyethyl starch solution in critically ill patients. Minerva Anestesiol (2006) 1.67
Hydroxyethyl starch--can the safety problems be ignored? Wien Klin Wochenschr (2004) 1.61
Resuscitating patients with early severe sepsis: a Canadian multicentre observational study. Can J Anaesth (2007) 1.52
Intravascular volume replacement therapy with synthetic colloids: is there an influence on renal function? Anesth Analg (2003) 1.49
Influence of different volume therapies on platelet function in the critically ill. Intensive Care Med (1996) 1.47
The balanced concept of fluid resuscitation. Br J Anaesth (2007) 1.45
Retracted Volume therapy in the critically ill: is there a difference? Intensive Care Med (1998) 1.26
Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emerg Med (2008) 1.25
Pruritus precipitated by hydroxyethyl starch: a review. Br J Dermatol (2005) 1.23
Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet (2005) 1.13
Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev (2008) 1.11
Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients. Crit Care Med (1996) 1.03
Randomized trial of hydroxyethyl starch versus gelatine for trauma resuscitation. J Trauma (1999) 1.02
Effects of hetastarch and albumin on coagulation in patients with septic shock. J Clin Pharmacol (1988) 1.01
Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Crit Care Med (1982) 0.93
Retracted Influence of different volume therapy regimens on regulators of the circulation in the critically ill. Br J Anaesth (1996) 0.92
Does the type of volume therapy influence endothelial-related coagulation in the critically ill? Br J Anaesth (1995) 0.91
Hyperoncotic colloids in shock and risk of renal injury: enough evidence for a banning order? Intensive Care Med (2008) 0.90
Fluid resuscitation with colloids of different molecular weight in septic shock. Intensive Care Med (2004) 0.90
Hydroxyethyl starch (HES) does not directly affect renal function in patients with no prior renal impairment. J Clin Anesth (2001) 0.89
A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circ Shock (1993) 0.86
Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Can J Anaesth (2008) 0.85
Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion. Crit Care Med (1989) 0.83
Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World J Surg (1998) 0.83
The influence of volume therapy and pentoxifylline infusion on circulating adhesion molecules in trauma patients. Anaesthesia (1996) 0.82
[Effect of hydroxyethyl starch solution on kidney function in surgical intensive care patients]. Anasthesiol Intensivmed Notfallmed Schmerzther (1997) 0.78
Fluid resuscitation: colloids vs. crystalloids. Blood Purif (2002) 0.77
[Comparative study of the modification of blood, blood coagulation, cardiovascular circulation by 3% modified, fluid gelatins and 6% low-molecular weight hydroxyethyl starch]. Infusionsther Klin Ernahr (1987) 0.77
Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA (2009) 13.00
Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med (2008) 11.00
Randomized trials stopped early for benefit: a systematic review. JAMA (2005) 8.43
Screening for Occult Cancer in Unprovoked Venous Thromboembolism. N Engl J Med (2015) 7.39
A guide for the design and conduct of self-administered surveys of clinicians. CMAJ (2008) 6.72
Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol: a randomized controlled trial. JAMA (2012) 6.69
High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med (2013) 6.56
Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ (2009) 6.27
Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA (2010) 5.90
Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis. JAMA (2002) 5.57
An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med (2006) 5.29
A systematic review and meta-analysis of studies comparing mortality rates of private for-profit and private not-for-profit hospitals. CMAJ (2002) 4.84
Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ (2002) 4.70
Permissive Underfeeding or Standard Enteral Feeding in Critically Ill Adults. N Engl J Med (2015) 4.54
A systematic evaluation of the quality of meta-analyses in the critical care literature. Crit Care (2005) 4.51
Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med (2010) 4.39
Need for expertise based randomised controlled trials. BMJ (2005) 4.34
An observational study of orthopaedic abstracts and subsequent full-text publications. J Bone Joint Surg Am (2002) 4.25
Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med (2014) 3.96
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care (2013) 3.90
Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J (2009) 3.52
Drug shortages in Canadian anesthesia: a national survey. Can J Anaesth (2013) 3.51
The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med (2013) 3.43
Family satisfaction with care in the intensive care unit: results of a multiple center study. Crit Care Med (2002) 3.36
Barriers to full-text publication following presentation of abstracts at annual orthopaedic meetings. J Bone Joint Surg Am (2003) 3.36
Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg (2012) 3.36
The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study*. Crit Care Med (2014) 3.29
Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. JAMA (2012) 3.26
Quality of care in for-profit and not-for-profit nursing homes: systematic review and meta-analysis. BMJ (2009) 3.22
Intensive care unit quality improvement: a "how-to" guide for the interdisciplinary team. Crit Care Med (2006) 3.15
Patient and healthcare professional factors influencing end-of-life decision-making during critical illness: a systematic review. Crit Care Med (2011) 3.07
Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients. Crit Care Med (2006) 3.06
Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med (2015) 2.97
Methodologic issues in systematic reviews and meta-analyses. Clin Orthop Relat Res (2003) 2.90
Rationing critical care beds: a systematic review. Crit Care Med (2004) 2.86
The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit Care Med (2015) 2.85
The Very Elderly Admitted to ICU: A Quality Finish? Crit Care Med (2015) 2.77
Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med (2009) 2.77
Payments for care at private for-profit and private not-for-profit hospitals: a systematic review and meta-analysis. CMAJ (2004) 2.76
Intensive care unit bed availability and outcomes for hospitalized patients with sudden clinical deterioration. Arch Intern Med (2012) 2.75
Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One (2012) 2.75
Prolonged therapeutic hypothermia after traumatic brain injury in adults: a systematic review. JAMA (2003) 2.73
End-of-life care for the critically ill: A national intensive care unit survey. Crit Care Med (2006) 2.61
A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care (2011) 2.60
Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med (2011) 2.59
Percutaneous dilatational tracheostomy versus surgical tracheostomy in critically ill patients: a systematic review and meta-analysis. Crit Care (2006) 2.55
Age of transfused blood in critically ill adults. N Engl J Med (2015) 2.52
Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med (2009) 2.45
Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis. BMJ (2007) 2.44
Activated protein C and septic shock: a propensity-matched cohort study*. Crit Care Med (2012) 2.39
The design and interpretation of pilot trials in clinical research in critical care. Crit Care Med (2009) 2.38
Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ (2007) 2.33
Propofol-related infusion syndrome heralding a mitochondrial disease: case report. Neurology (2013) 2.33
Treatment of new-onset atrial fibrillation in noncardiac intensive care unit patients: a systematic review of randomized controlled trials. Crit Care Med (2008) 2.33
Mortality predictions in the intensive care unit: comparing physicians with scoring systems. Crit Care Med (2006) 2.29
Written informed consent and selection bias in observational studies using medical records: systematic review. BMJ (2009) 2.27
A systematic review of studies comparing health outcomes in Canada and the United States. Open Med (2007) 2.26
Dying in the ICU: perspectives of family members. Chest (2003) 2.25
Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest (2013) 2.24
Ultrasound-Guided Subclavian Vein Catheterization: A Systematic Review and Meta-Analysis. Crit Care Med (2015) 2.21
Can erythropoietin eradicate red cell transfusions in the critically ill? Crit Care Med (2006) 2.21
Systematic reviewers neglect bias that results from trials stopped early for benefit. J Clin Epidemiol (2007) 2.20
Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis (2004) 2.17
Management of the critically ill patient with severe acute pancreatitis. Crit Care Med (2004) 2.16
Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*. Crit Care Med (2015) 2.16
Integrating mortality and morbidity outcomes: using quality-adjusted life years in critical care trials. Am J Respir Crit Care Med (2012) 2.15
The future of clinical trials evaluating blood substitutes. JAMA (2008) 2.14
Randomized, controlled clinical trials in sepsis: has methodological quality improved over time? Crit Care Med (2002) 2.10
Decision-making in the ICU: perspectives of the substitute decision-maker. Intensive Care Med (2002) 2.09
Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med (2008) 2.02
Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med (2013) 2.01
Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med (2003) 2.01